GEV vs HON: Which Is the Better Buy?

Side-by-side comparison of GE Vernova Inc. and Honeywell International Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-25.
GE Vernova Inc. Β· Industrials
$1,014.75
-16.2% upside to fair value
Med Conviction Grade C+
VS
Honeywell International Inc. Β· Industrials
$222.25
-5.5% upside to fair value
Grade D High Quality
QuantHub Verdict
HON has more upside to fair value (-5.5%). HON trades at a lower forward P/E (15.7x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric GEV HON
Current Price $1,014.75 $222.25
Fair Value Estimate $850.00 $210.05
Upside to Fair Value -16.2% -5.5%
Market Cap $270.3B $70.4B
Forward P/E 34.3x 15.7x
EV / EBITDA 25.6x 13.1x
Price / Sales 6.6x 1.9x
Price / FCF 22.0x 17.1x
Revenue Growth YoY +15.0% -6.9%
Gross Margin 21.3% 36.9%
Operating Margin 5.9% 14.9%
Return on Equity 30.0% 23.6%
Dividend Yield 0.17% 0%
FCF Yield 4.5% 5.84%
Analyst Consensus Buy Strong Buy
Investment Thesis
GEV β€” GE Vernova Inc.
GE Vernova is the premier pure-play on the electricity side of the AI infrastructure supercycle. Its Power (heavy-duty gas turbines) and Electrification (grid equipment) segments are structurally supply-constrained, backed by a record $176B backlog that management says is 'mostly sold out through 2030.' The company raised FY2026 guidance for a second straight quarter to $45.5-46.5B revenue and $1…
HON β€” Honeywell International Inc.
Honeywell International Inc. operates as a diversified industrial conglomerate with a strong presence in multiple sectors including aerospace, building technologies, and performance materials. The company demonstrates high business quality with a durable competitive moat supported by strong margins, a 23.6% return on equity, and solid free cash flow generation of $16.78 per share. However, recent…
Accumulation Zones
Metric GEV HON
Zone Low $640.00 $157.54
Zone High $723.00 $178.54
In Buy Zone? No No
← GEV Research    HON Research β†’    All Research